← All stocks

Annovis Bio, Inc.

ANVS Net buying
CIK 0001477845 #4495 in the set updated 17 Sep 2026
Bought (12 mo)
$4.30M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$4.30M
+$4.30M against sales at will

By person

5 insiders · 15 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Hoffman Michael B
Director
$4.10M (14)
+$4.10M
3,364,883
$6.39M
+137.6%
Maccecchini Maria-Luisa
President & CEO
$200.00K (1)
+$200.00K
1,212,020
$2.30M
+13.4%
Bruck Claudine
Director
13,709
$26.05K
+108.8%
McCarthy Reid
Director
9,305
$17.68K
+27.4%
Walsh Andrew
Vice President, Finance
500
$949.95

No percentages here. This company's share count has moved by a factor of 3.1 over the window, from 13,797,242 to 42,606,152 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Hoffman Michael B
20 May 2026
Director
Buy
54,933
$1.90
$104.37K
Hoffman Michael B
20 May 2026
Director
Buy
18,849
$1.80
$33.93K
Hoffman Michael B
20 May 2026
Director
Buy
2,562
$1.75
$4.48K
Hoffman Michael B
2 Apr 2026
Director
Buy
713,800
$2.10
$1.50M
Hoffman Michael B
8 Dec 2025
Director
Buy
15,000
$4.24
$63.60K
Hoffman Michael B
8 Dec 2025
Director
Buy
30,000
$4.34
$130.19K
Hoffman Michael B
24 Nov 2025
Director
Buy
28,096
$4.15
$116.60K
Hoffman Michael B
24 Nov 2025
Director
Buy
415
$4.14
$1.72K
Hoffman Michael B
24 Nov 2025
Director
Buy
9,200
$3.85
$35.42K
Hoffman Michael B
24 Nov 2025
Director
Buy
1,489
$4.13
$6.15K
Hoffman Michael B
21 Nov 2025
Director
Buy
10,000
$3.50
$35.00K
Hoffman Michael B
21 Nov 2025
Director
Buy
10,000
$3.49
$34.90K
Hoffman Michael B
14 Nov 2025
Director
Buy
15,000
$2.11
$31.65K
Hoffman Michael B
28 Oct 2025
Director
Buy
975,610
$2.05
$2.00M
Maccecchini Maria-Luisa
28 Oct 2025
President & CEO
Buy
97,561
$2.05
$200.00K

What was left out

Form 4 filings counted 9
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 5 Feb 2020